CTOs on the Move

Arkion Life Sciences

www.arkionls.com

 
Arkion Life Sciences is a New Castle, DE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.arkionls.com
  • 551 Mews Dr Ste J
    New Castle, DE USA 19720
  • Phone: 302.504.7400

Executives

Name Title Contact Details

Similar Companies

VISTA HealthPlan

VISTA HealthPlan is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Vault Health

The Vault Health platform provides a robust and flexible technology stack at the foundation of a multimodal healthcare service ecosystem. The platform features a powerful suite of digital healthcare tools designed to tackle a broad scope of modern medical use cases, including individual care, population health, and clinical trials. The Vault digital healthcare toolkit includes on-demand telehealth consultations and sample supervision, patient and provider communications, in-person and remote appointment management, longitudinal care management, and beyond. Vault gravitates to opportunities and partnerships that empower them to share and expand their platform`s capabilities and impact.

Athena Health Care Systems

Athena Health Care Systems is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Athena Health Care Systems is based in Farmington, CT. You can find more information on Athena Health Care Systems at www.athenahealthcare.com

Witham Health Services

Witham Health Services is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Witham Health Services is based in Lebanon, IN. You can find more information on Witham Health Services at www.witham.org

Ritter Pharmaceuticals

Ritter Pharmaceuticals, Inc. is a specialty pharmaceutical company developing therapeutics based upon colonic adaptation to treat gastrointestinal diseases with an initial focus on lactose intolerance. Colonic adaptation improves colon function by selectively increasing the growth of beneficial bacteria in the colonic ecosystem (digestive tract). Ritter Pharmaceuticals, Inc. is rapidly establishing itself as the world`s leader in lactose intolerance research based upon its scientific team and their cutting edge research in this field. RP-G28, Ritter`s lead product, has been studied in a Phase 2 trial and is a first-in-class compound. RP-G28 has the potential to become the first FDA-approved drug for the treatment of lactose intolerance, a debilitating disease which affects over 1 billion people worldwide.